{"name":"Entos Pharmaceuticals Inc.","slug":"entos-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"COVIGENIX VAX- 002","genericName":"COVIGENIX VAX- 002","slug":"covigenix-vax-002","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"COVIGENIX VAX- 002","genericName":"COVIGENIX VAX- 002","slug":"covigenix-vax-002","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQR1Bnend6ZVJVSF9PaWYtRy1BMUp3UVVaNTh3UkFPTTZMTHN6bEZfNk5odjE4N2FFMmxHVWRSbEZ0cU9ldUU3YmhmQW1ZNm9tOWZTZVJST1lNMFgyWmVfWF95c3ZjWnBhS2RsZ2FiSm4xbkp1QWdvTDBRQ25QV0hzR1JmUkVqZE5XOWNCTUctY2lCd2ItNmVHMHdEcnQ2cVp5OGZkeGMzYzdtTGdDSElSZXdTVXdZVEh6TVJmUTQxUG5QNjB0cE5YSVhxcFowLTNwV2JxVF9MaXRFejJzOTRoZGpiVU5LZFpyS3FCMmZIdkR1a01yOWtyUU1UeWZtSnBfYmZrQmpHcm0?oc=5","date":"2025-05-22","type":"pipeline","source":"PR Newswire","summary":"CureDuchenne Ventures Invests in Entos Pharmaceuticals for Development of a Redosable, Full-Length Dystrophin Gene Therapy - PR Newswire","headline":"CureDuchenne Ventures Invests in Entos Pharmaceuticals for Development of a Redosable, Full-Length Dystrophin Gene Thera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE41WUcwd3UxSVZrNE52SzMwaDYwX1J2TmFZNmx3R0hSWUM3b0laUklCak1CX042c2JVZzc3RVgwbzdrR1ZzUTB5SVFjQ0ZzQnlZNmNDY01vR09yLVZXRmUtSk1LQXRVdHZ0c2JkXzNfNHcxWHY0?oc=5","date":"2025-04-12","type":"deal","source":"Labiotech.eu","summary":"Top biotech deals of April 2025 - Labiotech.eu","headline":"Top biotech deals of April 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxQZ0QybW8zVWN3U3hIX2xmZmpCZGstLV9HWXUzd2xxdlRkc3ZGVm94cFlsRE1lVGI3dGpNbEs3eTlYNWVuaDY4MHJpdW5IVVp2QVBneUtXV3NnR0VpellyNlFBXzJZQnRDM3pHSFdpOHdfMUUxcXFMNFRqdmo3cFZGV1E4MkpPUEdQcEZaVnVfS0V0UURFOU9Xb2FDejZ1b0ZrUkpjbVVtYk43VUxMUHVxRUZIaF9GQjgwajhnWWdxYjNxYVliVzRwRnVzZ0ZkT0otOGMzOXJkbTl1MFJOb1VXN3NVSlpqVDVJU3NhcTFIeUpfbUJTRWxFTXkzblJseWNVRDRTTEM0OVJqMGpIdzhiOE9XMWJyMnlPbjhLNXIzS1pmdjE2VFRXNWk5N3VTSTJhcUtrM2R2UmJ3Y3d1LUhrUjBXQnR4bGJTdEc0Mw?oc=5","date":"2025-03-15","type":"pipeline","source":"Business Wire","summary":"Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized Lipodystrophy Program - Business Wire","headline":"Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) f","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AJBVV95cUxNVXlqNWdYRm1RWGN6LVhQQTBEdm5mYV9VTGNXSEc1OF9BSTJpcE5UV1BSOGFBZWtJdnJjRE91U1JXVmdraUNsQ1JKbnptTDM5MlRQYlpUTmFUbUlSZ2IxM3VuYWpNc292X1dwMzh2VVRrQkt5VExCdmF4b1p0MDd3dkV4TF8wclU0QzQ1eDZ2YXRGQ2JLbFZOS1lPdklJdlUwdUFrTnEwUFJXQWNIZFZsdjdGSXpOb2M3QVBHRWx1VkFUWll3emFpZE5sUXd0bzNub0FFVVFPWDMwQWpKTnlNU2RycVRoTHNBRFhWdnowTlRQV3plcXpVYlRrYzVXQ3FCLUgzMERPZDJFYWRRNmZpNGFnLWtUYWZmazdFMlVUaHpjajMwRXozNTQ4dU5Kd0JnaWNuYm82REpramtLREJsdE1wR0dhMEl2c1c5MHlsX3A5dzkxZm04Vg?oc=5","date":"2025-03-11","type":"deal","source":"Business Wire","summary":"Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics - Business Wire","headline":"Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQbGdVTDV6YkRBQm54Z1Y5UmdoMmprT296aEZYR28tM0pCQWZnODVwNE9LNGE4WnFhZkFxUlp4eDk0SUFjSThoclRlOExDZTFYM2x4dTVtbzVnbmRzWDFTM3FqZUJsVVlQeUg4SFBiNjdxSjJyRTlrWC1sTjlBWXNtV01hWTVqUFcwNGpJTEQxdlJmdjFDNVB5WUxfeWRxdzdMQ00yS0JKdWoyM1lYVmNFaUxZcG5hYXBKc1JDbENHallyc3laRXgxOWNkTjkxRnVPbWJqQWtRVUVUWEVKaE5PcHR3OWtrYU9aS0UwYWVicl9zS2Y5ZmRTZUQ3R2E?oc=5","date":"2024-06-10","type":"regulatory","source":"Business Wire","summary":"Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster - Business Wire","headline":"Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNQ3M0VUZrVmpkT2dpSFRUeVVwNUNrYVBZNDlrMVJ2RTFIQ3pCRFVPSDhBMlZGNUVmRVYyRlVCOF9pUlFlNHB0cHc3X2VWczB1SjlIaDdodS1nYzRQS0YxMjUxUFR0QTA2alRHRTBsUDNZYktFWXI2bzg3QnY4djZVb1ZHSDlhU2NyQ2V4a1F0X2hNOTlHcV9wd3FUUkNmdDBwc21nSjBvX05vN3RF?oc=5","date":"2024-03-06","type":"pipeline","source":"Fierce Pharma","summary":"Argonaut's journey continues with $45M in new financing for facility expansion - Fierce Pharma","headline":"Argonaut's journey continues with $45M in new financing for facility expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9yNWVpYS0tUzNFZmJCX29ZbUFNMmYxQ0VuTGhQVFBQTExQSFdPMXNsTEQtZFItbTJSUUdfWFZyODNiUEJMX00xTUVFZGh5V3F1Y0hIeDJFbEdvR0xDTm9tSkt0MXVpRGIxVlFpTG1SOWhVNnRUempQM3dNRTlNQQ?oc=5","date":"2022-04-14","type":"pipeline","source":"Pharma Voice","summary":"With Lilly on board, Entos' medical chief champions genetic platform with 'unlimited' potential - Pharma Voice","headline":"With Lilly on board, Entos' medical chief champions genetic platform with 'unlimited' potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxONkdIZXpBcHJhNjFmVGV4MUthWmRSRzZSZ213WXNIalRhYk9yVVNaN0lrSzlOYjNGM3lRSklIekZjbC1IZGhNTy11dkgtSTdWWVRZaU0xVW1FSG1mcVBLT3ZlS2xyX2F5YmtMYlNJNmRZZ29Pdzd5RnRlTm5ZVzlRSk4xUTdheVU4WTRtSUJ5RkxhQ0tvWlhtNFhhLURUcjFCUjBBS1JUZENuMndDNzA1SlFuRFFxeUxrNFd3S3BwQkE3cDZj?oc=5","date":"2022-01-06","type":"deal","source":"Eli Lilly","summary":"Lilly and Entos Pharmaceuticals Enter into Research and Collaboration Agreement to Support the Development of Innovative Therapies in Multiple Neurologic Indications - Eli Lilly","headline":"Lilly and Entos Pharmaceuticals Enter into Research and Collaboration Agreement to Support the Development of Innovative","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPcXdZUG1Da2RPNUFWM1JHeEZxMkotdTZCQ2lHVUVYQ3Y3VVBBRFp6a3FWYmh2dmhqNUNUS0pmcW05TVJ6c3lJaWRYYkZWS05FeE9nQVlHaGRpalNEZThCQVlnMXhVM0JVdC1IVWFMVlVuM01OakZYYmVZdEdPY3hLVi1KUnF2WExJUHdOY1VWdEZJTDRYdzgxSWlMNE5heFI4?oc=5","date":"2022-01-06","type":"pipeline","source":"Fierce Biotech","summary":"Eli Lilly taps Entos' delivery tech in $50M-plus nucleic acid pact - Fierce Biotech","headline":"Eli Lilly taps Entos' delivery tech in $50M-plus nucleic acid pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNQldhcWgtQUd3dlNfRm9XakQwUE0wb0JvOHVWNnRxanVCeC1SMlkyZ3g4VU03RjJxTFFuaHo2Zmg5TFlZWVFrZUZyMkV5T0liVm9ZakFxOXlNVGp1TG9pODlsbFJ5WHdPY1BvTGVLaHRXOHJRVWp1OFB6VUp0VUxLaHlRcVFia2JPdUVQSTRmakxmRUhsbE5sNVphNlBCb2ZuX3FaR2h2NFg?oc=5","date":"2020-12-11","type":"pipeline","source":"edmontonglobal.ca","summary":"The Edmonton Region’s pharmaceutical industry – it’s an opportunity right now - edmontonglobal.ca","headline":"The Edmonton Region’s pharmaceutical industry – it’s an opportunity right now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxOMWExYk9EN3dzNElOd0RiLVYxYnJoMjJWSVIxeVdFS2R6SXVKWVktX29Zalp1TzNhWmR1a3A4MG9KdGtSQ3lwaFBobEs1TlhWOFBOejVmQ1Rhb2ZSdlZ4RGl3N3ktMko5bWRFMk5YU3dDbExXR1hXSE9mNEpjbUtRQWx5U3lteEl4c3loUUdTR2pLNkJCbFRuR2FNVHBWTEtXajZzUUZXR2Z6WkVTVUMyZVFBTXZqM050ZU5QVm8zeWdQWnZkOFZHNllzVzdIUW5ocmdfWHBWZkpGV2RkdFJZWUlqMGFfaFItSThmem96cWNtVjU5d1Z4MXZSSHFkQWVtLUg5WUxtZ3UtNG1tSjRsd1FVQnNMWmJlcnQxY2hJaW50X0Z3NTZiamRsWnEtXzRFUF96Tg?oc=5","date":"2020-10-28","type":"deal","source":"University of Alberta","summary":"University of Alberta-hosted institute Applied Pharmaceutical Innovation partners with Entos Pharmaceuticals to manufacture COVID-19 vaccine in Alberta - University of Alberta","headline":"University of Alberta-hosted institute Applied Pharmaceutical Innovation partners with Entos Pharmaceuticals to manufact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPTmgzWWdZM1VteVdaS1BzekV2aENTdy1DM0FpU3puTWdfc0NnS3h5SDRNazBwX1ZIMVdZdzdXbXF4OGRPenk4a2FxV1Y5eHN1NXhzU3dLdkZVaE9JankzVkNjWEFuVHk1bzhSN3lQYXBqU19HYjNCSTRIS05mdGdGTU9yXzVZcUlWdzVRUjNlcWt0WWMzdWZ1SE4tYS12OGNFMVZGZERWeDdTY2RaUVRWdzgteEZUdVQwdGViUTNZM1g3M1E2NGZISnZ5Q2Mxam8?oc=5","date":"2019-10-03","type":"deal","source":"News-Medical","summary":"Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company - News-Medical","headline":"Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company - News","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}